SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?


To: Claud B who wrote (2450)2/21/1998 3:00:00 PM
From: Bradpalm1  Read Replies (2) | Respond to of 7041
 
<<What the analyst describes in her report fits exactly with what I have heard about the other company.>>

Well Claud, I then hope that Vasomax' NDA proposal is ready to go since 'the other company' will be hearing about FDA approval of their oral ED product within the next 7-10 days.

Bradpalm1



To: Claud B who wrote (2450)2/21/1998 3:36:00 PM
From: Linda Kaplan  Read Replies (1) | Respond to of 7041
 
Claud,

Yeah, but Ms Feldman wasn't reporting on the other company with a nauseating ED drug.<g> She was reporting on VVUS and ZONA and Pfizer. To mix a fourth company into the stew is a pretty big mistake to make. Did you ask her?

Zooom!
Linda